PROBIOTICS FOR IBS (IRRITABLE BOWEL SYNDROME)
Irritable bowel syndrome (IBS) is a common gastrointestinal condition that affects the intestines and its typical syndroms are;
• Abdominal pain
• Diarrhea or constipation
• Excessive flatus
• Abdominal bloating
• Changes in frequency of bowel movement
• Depression and anxiety (due to stress)
It is estimated that 15-20% of the population are affected with this multi-factorial condition but due to lack of specific diagnosis and a cure, most people with IBS symptoms are treated with limited therapies that include antibiotics, laxatives, antidepressants and antagonist agents. Alternative treatments with newer medicine have modest efficacy and it is important to adopt an efficient, safe and practical solutions.
Probioticsfor is here to inform you with current probiotics that are used for irritable bowel syndrome. Recent studies are focused on intestinal microbiota, because alterations in intestinal bacteria dynamics might have a causal role in IBS development. Malfermentation and abnormal colonic fermentation due to food intolerances or disturbed intestine microbiota are associated with IBS as well.
Probiotics, especially the genera Bifidobacterium and Lactobacillus have been the most studied, are used in many randomized, double blinded studies related to IBS and so far the results showed that probiotics can be use to prevent onset of symptoms associated with IBS. It is believed that more detailed studies in the future can help us to develop effective strategies.
It is important to consult your physician before taking any probiotic supplements if you have IBS or other symptoms associated with IBS.
PROBIOTIC STRAINS THAT PRODUCED FAVORABLE RESULTS
• Bifidobacterium bifidum
• Bifidobacterium lactis
• Lactobacillus acidophilus
• Lactobacillus casei
• Pediococcus pentosaceus
Andresen, V., & Baumgart, D. C. (2006). Role of probiotics in the treatment of irritable bowel syndrome: potential mechanisms and current clinical evidence. International Journal of Probiotics and Prebiotics, 1(1), 11.
Brenner, D. M., Moeller, M. J., Chey, W. D., & Schoenfeld, P. S. (2009). The utility of probiotics in the treatment of irritable bowel syndrome: A systematic review. American Journal of Gastroenterology, 104(4), 1033-1049.
Öhman, L., & Simrén, M. (2010). Pathogenesis of IBS: role of inflammation, immunity and neuroimmune interactions. Nature Reviews Gastroenterology and Hepatology, 7(3), 163-173.